Panchsheel Organics Ltd
BSE:531726
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
P
|
Panchsheel Organics Ltd
BSE:531726
|
1.4B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
978.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.3B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.8B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
273B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
150.2B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
95.7B EUR |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Panchsheel Organics Ltd
Glance View
Panchsheel Organics Ltd. engages in the manufacture of pharmaceuticals and medicinal chemical products. The company is headquartered in Mumbai, Maharashtra. The firm's products include steroids and hormones, veterinary products, over-the-counter products, oncology products, nutraceutical products, micro pellets and direct compression, fitness and healthcare products, and product development and testing laboratory. The firm offers a range of products under categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis and erectile dysfunction, among others. Its API product range includes Acamprosate Calcium, Amiodarone and Leflunomide. Its hormones and steroids product range includes Cyproterone Acetate, Desogestrel and drosperinone. Its nutraceuticals and healthcare products include Alpha Linolenic Acid (ALA) Powder and Phytosterol.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Panchsheel Organics Ltd is 12.7%, which is below its 3-year median of 15.9%.
Over the last 3 years, Panchsheel Organics Ltd’s Operating Margin has decreased from 19.7% to 12.7%. During this period, it reached a low of 12.7% on Sep 30, 2025 and a high of 19.8% on Dec 31, 2022.